Gsk (GLAXF) Capital Leases (2016 - 2018)

Gsk's Capital Leases history runs 3 years deep, the most recent figure standing at $56.6 million for Q4 2018.

• In Q4 2018, Capital Leases fell 0.83% year-over-year to $56.6 million; the TTM figure through Dec 2018 stood at $56.6 million (down 0.83% YoY), while the FY2018 annual figure was $58.8 million, up 6.08% from the prior year.
• Capital Leases was $56.6 million for Q4 2018 at Gsk, down from $57.1 million in the prior quarter.
• In the past five years, Capital Leases ranged from a high of $57.1 million in Q4 2017 to a low of $51.0 million in Q4 2016.
• Historically, Capital Leases has averaged $54.9 million across 3 years, with a median of $56.6 million in 2018.
• The sharpest annual moves came in 2017 and 2018: Capital Leases rose 12.0% in 2017, then retreated 0.83% in 2018.
• A 3-year view of Capital Leases shows it stood at $51.0 million in 2016, then advanced by 12.0% to $57.1 million in 2017, then dropped by 0.83% to $56.6 million in 2018.
• The last three Capital Leases figures came in at $56.6 million (Q4 2018), $57.1 million (Q4 2017), and $51.0 million (Q4 2016), per Business Quant data.